galactose has been researched along with ginsenoside rg1 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Danieli, B; Falcone, L; Gebhardt, S; Monti, D; Riva, S; Schubert-Zsilavecz, M | 1 |
| Chen, J; Li, C; Li, T; Liu, J; Mu, X; Wang, Y; Xu, C; Zeng, J; Zhang, M; Zhu, J | 1 |
| Hu, W; Jing, P; Wang, L; Wang, Y; Yong, J; Zhang, Y | 1 |
| Fan, Y; Huang, G; Jia, D; Wang, Y; Xia, J; Zhang, M; Zhang, Y | 1 |
| Cai, D; Chen, L; Jing, P; Li, J; Wang, L; Wang, Y; Yao, X; Zhang, Y | 1 |
| He, L; Ling, L; Wang, Y; Wei, T; Xiong, Z | 1 |
| Chen, L; Chen, X; Liu, Y; Wang, Y; Wang, Z; Xia, J; Xiang, Y; Yao, H | 1 |
| Chen, LB; Chen, XB; Li, J; Liu, Y; Qiu, Z; Wang, L; Wang, YP; Wang, ZL | 1 |
| Jia, D; Li, J; Ran, R; Shao, Y; Sun, J; Wang, L; Wang, Y; Zhang, J; Zhang, L; Zhang, M; Zhang, Y | 1 |
| Gu, RZ; Lan, R; Qin, XY; Wang, L; Zhang, WH; Zhong, SJ | 1 |
| He, S; Jiang, R; Qi, R; Wang, L; Wang, Y; Wang, Z; Xiao, H | 1 |
| Cheng, D; He, L; Liu, X; Wang, X; Xiong, Z | 1 |
| Chen, L; Jiang, Y; Jin, H; Lin, Y; Lv, W; Zheng, Y | 1 |
| Du, K; Hu, L; Ran, J; Wang, L; Wang, Y; Wang, Z; Wu, M; Xiao, H | 1 |
14 other study(ies) available for galactose and ginsenoside rg1
| Article | Year |
|---|---|
Regioselective enzymatic glycosylation of natural polyhydroxylated compounds: galactosylation and glucosylation of protopanaxatriol ginsenosides.
Topics: Carbohydrate Sequence; Galactose; Ginsenosides; Glycosylation; Mass Spectrometry; Molecular Sequence Data; Panax; Plants, Medicinal; Sapogenins; Saponins; Triterpenes | 2001 |
Ginsenoside Rg1 prevents cognitive impairment and hippocampus senescence in a rat model of D-galactose-induced aging.
Topics: Aging; Animals; Antioxidants; beta-Galactosidase; Cell Count; Cellular Senescence; Cognition Disorders; Cytokines; Dentate Gyrus; Disease Models, Animal; Down-Regulation; Galactose; Ginsenosides; Hippocampus; Inflammation Mediators; Male; Membrane Glycoproteins; Nestin; Neural Stem Cells; Neurogenesis; Rats, Sprague-Dawley; RNA, Messenger; SOXB1 Transcription Factors; Staining and Labeling; Telomerase; Telomere Homeostasis | 2014 |
The positive effects of Ginsenoside Rg1 upon the hematopoietic microenvironment in a D-Galactose-induced aged rat model.
Topics: Aging; Animals; Anti-Inflammatory Agents; Antioxidants; beta-Galactosidase; Bone Marrow; Cell Cycle; Cell Proliferation; Cellular Senescence; Cytokines; Galactose; Ginsenosides; Hematopoiesis; Male; Malondialdehyde; Mesenchymal Stem Cells; Models, Animal; Oxidative Stress; Panax; Plant Extracts; Rats, Sprague-Dawley; Reactive Oxygen Species; Stem Cell Factor | 2015 |
Mechanism of ginsenoside Rg1 renal protection in a mouse model of d-galactose-induced subacute damage.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Biomarkers; Cytoprotection; Deoxyguanosine; Disease Models, Animal; DNA Damage; Galactose; Ginsenosides; Glutathione Peroxidase; Glycation End Products, Advanced; Kidney; Kidney Diseases; Male; Malondialdehyde; Mice, Inbred C57BL; Oxidative Stress; Superoxide Dismutase | 2016 |
Protective Effect of Ginsenoside Rg1 on Hematopoietic Stem/Progenitor Cells through Attenuating Oxidative Stress and the Wnt/β-Catenin Signaling Pathway in a Mouse Model of d-Galactose-induced Aging.
Topics: Aging; Animals; Antioxidants; beta Catenin; Galactose; Ginsenosides; Glutathione Peroxidase; Glycogen Synthase Kinase 3 beta; Hematopoietic Stem Cells; Histones; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase; Vitamin E; Vitamins; Wnt Signaling Pathway | 2016 |
Ginsenoside Rg1 improves fertility and reduces ovarian pathological damages in premature ovarian failure model of mice.
Topics: Animals; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Estrous Cycle; Female; Fertility; Galactose; Ginsenosides; Mice; Mice, Inbred C57BL; Ovarian Follicle; Ovary; Primary Ovarian Insufficiency | 2017 |
Ginsenoside Rg1 Decreases Oxidative Stress and Down-Regulates Akt/mTOR Signalling to Attenuate Cognitive Impairment in Mice and Senescence of Neural Stem Cells Induced by D-Galactose.
Topics: Animals; Antioxidants; Cognitive Dysfunction; Galactose; Ginsenosides; Glutathione Peroxidase; Mice, Inbred C57BL; Neural Stem Cells; Oxidative Stress; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2018 |
Ginsenoside Rg1 ameliorates testicular senescence changes in D‑gal‑induced aging mice via anti‑inflammatory and antioxidative mechanisms.
Topics: Aging; Animals; Cellular Senescence; Galactose; Ginsenosides; Male; Mice; Testis | 2018 |
Protective effects of ginsenoside Rg1 on splenocytes and thymocytes in an aging rat model induced by d-galactose.
Topics: Aging; Aging, Premature; Animals; Anti-Inflammatory Agents; Cells, Cultured; Cellular Senescence; Disease Models, Animal; Galactose; Ginsenosides; Humans; Male; Medicine, Chinese Traditional; Oxidative Stress; Panax; Rats; Rats, Sprague-Dawley; Spleen; Thymus Gland | 2018 |
Ginsenoside Rg1 ameliorates the cognitive deficits in D-galactose and AlCl
Topics: Aging; Aluminum Chloride; Animals; Antioxidants; Apoptosis; Behavior Observation Techniques; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cognition; Cognitive Dysfunction; Disease Models, Animal; Fibroblast Growth Factor 2; Galactose; Ginsenosides; Hippocampus; Humans; Male; Membrane Glycoproteins; Mice; Panax; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2020 |
Ginsenoside Rg1 protects against d-galactose induced fatty liver disease in a mouse model via FOXO1 transcriptional factor.
Topics: Animals; Antioxidants; Cellular Senescence; Disease Models, Animal; Fatty Liver; Forkhead Box Protein O1; Galactose; Ginsenosides; Lipid Peroxidation; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred C57BL; Oxidative Stress; Protective Agents; Transcription Factors | 2020 |
Ginsenoside Rg1 improves pathological damages by activating the p21‑p53‑STK pathway in ovary and Bax‑Bcl2 in the uterus in premature ovarian insufficiency mouse models.
Topics: Animals; Aurora Kinase B; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Female; Galactose; Gene Expression Regulation; Ginsenosides; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Organ Size; Ovary; Primary Ovarian Insufficiency; Signal Transduction; Tumor Suppressor Protein p53; Uterus | 2021 |
Gensenoside Rg1 protects against lipopolysaccharide- and d-galactose-induced acute liver failure via suppressing HMGB1-mediated TLR4-NF-κB pathway.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Cell Line; Epithelial Cells; Galactose; Gene Expression Regulation; Ginsenosides; Glutathione; HMGB1 Protein; Humans; Interleukin-6; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Signal Transduction; Superoxide Dismutase; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2021 |
Ginsenoside Rg1 attenuates D-galactose-induced neural stem cell senescence via the Sirt1-Nrf2-BDNF pathway.
Topics: Aged; Brain-Derived Neurotrophic Factor; Galactose; Ginsenosides; Humans; Neural Stem Cells; Neurodegenerative Diseases; NF-E2-Related Factor 2; Quality of Life; Sirtuin 1 | 2023 |